Nasdaq GlobeNewswire

IPsoft Launches Amelia Healthcare Practice to Transform the Healthcare Workforce and Patient Experience with Cognitive AI

Del

NEW YORK, Sept. 26, 2017 (GLOBE NEWSWIRE) -- IPsoft, the leading digital labor company, is to launch a vertically focused portfolio of solutions for the healthcare industry based on its AI platform, Amelia. A series of Amelia Health Agent offerings are under development in a program of co-collaboration with healthcare providers, health systems, health insurers and life sciences organizations. The first releases will target high volume processes and interactions that will deliver tangible improvements for providers, insurers, carers and patients. 

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/04fe91f2-5d18-475f-b43e-7d1183aaba1b

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4758c05a-915d-4278-8f55-6ed323f7649f

A video accompanying this announcement is available at 
http://www.globenewswire.com/NewsRoom/AttachmentNg/1be90122-0c3d-499e-9a10-80da9d5262b5

The new practice builds on the positive results of Amelia implementations across industries to target the healthcare AI market, which is expected to reach $6.6 billion by 20211. 

"We have seen the hype about AI's ability to find cures for major diseases overnight.  Now it is time to recover AI's reputation by applying advanced cognitive technology to the daily operations of the sector in order to provide demonstrable benefits to patients and the organizations who treat them," said Chetan Dube, IPsoft President and CEO.  

In order to develop and lead this new global practice, IPsoft has appointed David Champeaux as its global Cognitive Director, Healthcare Solutions. David has deep experience in designing and leading technology-enabled transformations within the healthcare sector both in his previous role as a Partner in McKinsey & Company's Healthcare practice and McKinsey Digital, where he served clients in Europe, Australia and the US, and as Managing Director leading Accenture's UK Healthcare Strategy practice.

"Routine cognitive processes can take up to 51% of a nurse's and 17% of a doctor's time - which is frustrating when Health Systems struggle with affordability and workforce shortages and patients complain about access. With Amelia's unique combination of human-like conversational intelligence, advanced analytics and dynamic processes execution, we finally have the opportunity to transform healthcare by freeing up its human capital - addressing challenges in access, quality, and efficiency," said David Champeaux.

In hospitals, Amelia can have significant and immediate impact relieving those who should be caring for patients from routine interactions, by helping manage operational and administrative processes such as booking rooms and beds or coordinating patient transfers.

For chronic conditions, which account for 86%2 of healthcare spend in the US, Amelia can help health institutions establish sustainable delivery at scale of proactive, coordinated patient care plans. For example, she can streamline most administrative and operational arrangements, such as providing information, booking regular appointments and scheduling tests.

For health insurers, Amelia can help improve the customer experience and efficiency of routine member services. Amelia can deliver affordable 24/7 availability to answer eligibility and coverage questions, or initiate and manage claims. In parallel, by employing Amelia, health insurance providers will be able to connect back-end underwriting systems and processes to every customer conversation, delivering instant scale to their operations.

Amelia is the most human and comprehensive AI platform on the market. Uniquely, Amelia connects conversations to data and processes in order to provide a personalized service to every customer, at scale. Across the US, Europe and Asia, global organizations are employing Amelia to improve customer experience and drive enhanced productivity.

To learn more about how Amelia can transform business operations and customer interactions, visit ipsoft.com/amelia

About IPsoft
IPsoft automates IT and business processes for enterprises across a wide range of industries through the use of digital labor. Through its portfolio of world leading autonomic and cognitive solutions it provides services that allow its clients to secure competitive advantage. Headquartered in New York City, IPsoft has offices in 18 countries across the world and serves more than 500 of the world's leading companies directly as well as more than half of the world's largest IT services providers. To learn more about IPsoft's solutions please visit www.ipsoft.com.

Contacts

IPsoft
Daniela Zuin, 212-708-5521
Mobile: 917-822-0484
daniela.zuin@ipsoft.com
or
Finn Partners for IPsoft
Erica McDonald, 646-202-9784
Mobile: 732-713-2354
Erica.mcdonald@finnpartners.com

Frost & Sullivan, Artificial Intelligence & Cognitive Computing Systems in Healthcare

2 Centers for Disease Control and Prevention (CDC) Website Data




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: IPsoft via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

The Navigators Group, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger19.10.2018 22:01Pressemelding

STAMFORD, Conn., Oct. 19, 2018 (GLOBE NEWSWIRE) -- The Navigators Group, Inc. (NASDAQ:NAVG) (“Navigators” or the “Company”) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), in connection with its previously announced merger with a direct wholly owned subsidiary (“Merger Sub”) of The Hartford Financial Services Group, Inc. (“The Hartford”), expired at 11:59 p.m. Eastern Time on October 18, 2018. The expiration of the waiting period under the HSR Act satisfies one of the conditions to the closing of the merger, which remains subject to other closing conditions in the Agreement and Plan of Merger, dated as of August 22, 2018, by and among the Company, The Hartford and Merger Sub. About Navigators The Navigators Group, Inc. (NASDAQ: NAVG) (“Navigators” or the “Company”) is a global specialty insurance holding company. We provide customized insurance solutions designed to protect clients from the complex risk

ATTO Technology introduces the XstreamCORE® FC 7600 32Gb Fibre Channel to 12Gb SAS Hardware Accelerated Storage Controller19.10.2018 15:00Pressemelding

AMHERST, N.Y., Oct. 19, 2018 (GLOBE NEWSWIRE) -- ATTO Technology, Inc., a global leader of storage, network connectivity and infrastructure solutions for data-intensive computing environments for 30 years, announces availability of the ATTO XstreamCORE® FC 7600 storage controller. ATTO XstreamCORE FC 7600 is a standalone, accelerated storage controller that connects any external SAS device, such as a JBOD of HDDs or SSDs, a RAID array or external tape devices, and presents them isolated to individual hosts or shared over a Fibre Channel SAN fabric. It includes ATTO exclusive technologies, ATTO xCORE hardware acceleration processor and ATTO intelligent Bridging Architecture™, that combine to keep latency astonishingly low at three microseconds. For less than the price of a performance server, XstreamCORE FC 7600 enables up to 64 Fibre Channel connected clients to remotely access and share up to 240 SAS/SATA SSD or HDD devices via JBOD or JBOF at direct attached speeds with consistent, d

Biome Grow Introduces PEI Brand, Red Sands Craft Cannabis Co.19.10.2018 13:30Pressemelding

TORONTO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Biome Grow Inc. (“Biome” or the “Company”) (CSE:BIO) (FSE:6OTA) is pleased to introduce its fifth subsidiary company and brand, Red Sands Craft Cannabis Co. (“Red Sands”). Red Sands is located in Prince Edward Island (PEI) and will service both the local and tourist markets in that province with locally produced and regionally grown cannabis products. The Red Sands Craft Cannabis Co. brand reflects PEI’s iconic red sand beaches and the craft goods and services that are produced locally. Visually, it balances the vibrant, energetic colours with the calm nature that PEI is known for, setting the stage for the tailored cannabis products that Red Sands will offer. Though the smallest Canadian province both in terms of land area and population, with approximately 153,000 residents living on the Island, the province has a robust tourism industry. In 2017, the province set records with more than 1,000,000 overnight stays, by an estimated 1.56 million

CORRECTION - Elite Petro & Gas broadens financial services and signs a deal with Tabarak Investment Capital Limited18.10.2018 23:35Pressemelding

DUBAI, United Arab Emirates, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Today the President of Elite Petro & Gas, Mr. George Matharu and the President of Tabarak Investment Capital Limited (Investment Bank), Dr. Mohamed Ahmadi announced a deal in which the two companies will use their combined resources to execute physical commodity trades, and provide banking and finance facilities for oil and gas transactions. The alliance between the two entities will also allow compliance related activities to be carried out from two major international hubs of London and Dubai. This increases the international presence of both companies. Additionally, Elite Petro & Gas (“EPG”) has recently formed relationships with the owners of a number of high profile European, South American and Chinese projects, which EPG and Tabarak can work on together. Tabarak Investment Capital Limited is a regulated investment bank by Dubai Financial Services Authority and incorporated in the Dubai International Financial Centre.

Partnership Between Zaiput Flow Technologies and ThalesNano Set to Improve Process Intensification18.10.2018 15:21Pressemelding

BUDAPEST, Hungary and WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Zaiput Flow Technologies, a global leader in separation, and ThalesNano, the world leader in bench-top flow chemistry reactors, recently signed a distribution agreement and entered into a technology partnership that exploits the benefits of their combined technologies. Under the distribution Zaiput liquid-liquid phase separators and back pressure regulators are available via ThalesNano in Europe and a number of other countries on a non-exclusive basis, either separately or as part of a bundled offering with ThalesNano’s own microflow reactors. Within the framework of the technology partnership the companies will collaborate to promote adoption of the combined use of their technologies. “We are very excited to work with ThalesNano to offer better-integrated flow chemistry systems to our customers and streamline the work of both novice and experienced users in the flow chemistry space,” said Zaiput CEO, Dr. Andrea Ad

Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer18.10.2018 14:03Pressemelding

NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer. As a result, former Chief Medical Officer Juan Ruiz, M.D., Ph.D. will assume the role of Head of European Medical Affairs. The Company also announced the appointment of Neena Patil, J.D. as General Counsel and Corporate Secretary. Both Dr. Siffert and Ms. Patil report to Chief Executive Officer, Carsten Thiel, Ph.D. “I am very pleased to welcome João and Neena to Abeona, and confident in their abilities to make important contributions to the future growth of our company,” said Dr. Thiel. “João has an ideal blend of clinical, scientific, and regulatory experience to reference as we look to advance our clinical and pre-clinical can

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom